Clinical Practice Study
Copyright ©The Author(s) 2017.
World J Gastrointest Surg. Dec 27, 2017; 9(12): 270-280
Published online Dec 27, 2017. doi: 10.4240/wjgs.v9.i12.270
Table 3 Relationships between patient characteristics, operative outcome and postoperative pancreatic fistula grade
Characteristic dataPOPF (grading)
P-value95%CI
A (n = 58)B + C (n = 30)
Age, mean (SD)59.2 (11.3)58.8 (11.4)0.87456.67-61.46
BMI, median (IQR)23.1 (20.4, 25.1)23.1 (21.1, 26.5)0.80522.62-24.45
Albumin, median (IQR)34.7 (32, 38)35.4 (32, 37.9)0.60333.38-35.58
Total bilirubin, median (IQR)0.9 (2, 5)3.3 (1.2, 12)0.013.44-6.66
Pancreatic duct diameter (mm), median (IQR)3 (2, 5)3 (2, 4)0.1753.07-3.79
Operative time, median (IQR)480 (420, 600)480 (360, 540)0.49462.22-511.75
Blood loss (mL), median (IQR)800 (500, 1500)900 (600, 1500)0.071985.10-1616.95
LOH day, median (IQR)21 (14, 30)42.5 (30, 60)< 0.00128.14-46.32
Gender, n (%)
Male34 (58.6)12 (40.0)0.097
Female24 (41.4)18 (60.0)
DM, n (%)
No45 (77.6)24 (80.0)0.794
Yes13 (22.4)6 (20.0)
Hx of cardiovascular disease, n (%)
No42 (72.4)22 (73.3)0.927
Yes16 (27.6)8 (26.7)
PBD, n (%)
No20 (34.5)5 (16.7)0.079
Yes38 (65.5)25 (83.3)
Pancreatic texture, n (%)
Hard/Firm20 (35.1)7 (24.1)0.301
Soft37 (64.9)22 (75.9)
Type of resection, n (%)
PPPD24 (41.4)7 (23.3)0.093
PD34 (58.6)23 (76.7)
Duct, n (%)
Duct to mucosa46 (79.3)17 (56.7)0.026
Invagination12 (20.7)13 (43.3)
Stent, n (%)
No32 (55.2)22 (73.3)0.097
Yes26 (44.8)8 (26.7)
External vs Internal, n (%)
External8 (32.0)4 (50.0)0.42
Internal14 (68.0)4 (50.0)
Malignant, n (%)
No12 (20.7)4 (13.3)0.396
Yes46 (79.3)26 (86.7)
Final diagnosis, n (%)
CA ampulla23 (39.6)14 (46.7)0.33
CA pancreas8 (13.8)4 (13.3)
CA duodenal3 (5.2)0
CA distal CBD5 (8.6)6 (20.0)
Other19 (32.8)6 (20.0)
Age, n (%)
< 7047 (81.0)26 (86.7)0.505
≥ 7011 (19.0)4 (13.3)
BMI, n (%)
< 2542 (71.4)21 (70.0)0.812
≥ 2516 (27.6)9 (30.0)
Albumin, n (%)
≥ 3050 (86.2)27 (90.0)0.743
< 308 (13.8)3 (10.0)
Total bilirubin, n (%)
< 343 (74.1)13 (43.3)0.004
≥ 315 (28.9)17 (56.7)
Pancreatic duct diameter, n (%)
≥ 512 (20.7)11 (36.7)0.106
< 546 (79.3)19 (63.3)
Operative time, n (%)
< 42012 (20.7)9 (30.0)0.331
≥ 42046 (79.3)21 (70.0)
Blood loss, n (%)
< 100037 (63.8)17 (56.7)0.515
≥ 100021 (36.2)13 (43.3)